ucn-1028-c has been researched along with Osteoarthritis--Knee* in 1 studies
1 other study(ies) available for ucn-1028-c and Osteoarthritis--Knee
Article | Year |
---|---|
Regulation of MMP-13 expression by RUNX2 and FGF2 in osteoarthritic cartilage.
To understand the molecular mechanisms that lead to increased MMP-13 expression and cartilage degeneration during the progression of osteoarthritis (OA), we have investigated the expression of the transcription factor RUNX2 in OA cartilage and the regulation of MMP-13 expression by RUNX2 and FGF2 in articular chondrocytes.. RUNX2 and MMP-13 expression in human OA and control cartilage was analyzed by immunohistochemistry. The effects of RUNX2 over-expression, with or without FGF2 treatment, on MMP-13 promoter activity and enzyme accumulation were measured in articular chondrocytes. Inhibitors of MEK/ERK were assayed for their ability to block FGF2 and RUNX2 up-regulation of the MMP-13 promoter. We analyzed RUNX2 phosphorylation in response to FGF2.. Fibrillated OA cartilage exhibited increased RUNX2 immunoreactivity when compared to control cartilage. RUNX2 co-localized with MMP-13 in clusters of chondrocytes in fibrillated OA cartilage. RUNX2 over-expression in cultured chondrocytes increased their responsiveness to FGF2 treatment, which led to increased MMP-13 expression. Inhibitors of MEK/ERK signaling blocked up-regulation of the MMP-13 promoter by RUNX2 and FGF2, and also blocked the activation of RUNX2 by FGF2. FGF2 treatment of articular chondrocytes increased RUNX2 phosphorylation approximately 2-fold.. Increased expression of RUNX2 in OA cartilage may contribute to increased expression of MMP-13. FGF2, which is present in OA synovial fluid, activated RUNX2 via the MEK/ERK pathway and increased MMP-13 expression. However, it is unlikely that RUNX2 is a substrate of ERK1/2. RUNX2 expression and activation may be a significant step in the progression of OA by promoting changes in gene expression and chondrocyte differentiation. Topics: Animals; Blotting, Western; Butadienes; Cartilage, Articular; Case-Control Studies; Cattle; Cells, Cultured; Chondrocytes; Collagenases; Core Binding Factor Alpha 1 Subunit; Fibroblast Growth Factor 2; Flavonoids; Humans; Immunoprecipitation; Matrix Metalloproteinase 13; Mitogen-Activated Protein Kinase Kinases; Naphthalenes; Neoplasm Proteins; Nitriles; Osteoarthritis, Knee; Phosphorylation; Protein Kinase C; Signal Transduction; Transcription Factors | 2004 |